BioXcel Therapeutics, Inc. Financial Ratios — BTAIQ Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-100.23	-70.35	-49.93	-111.08	- -	- -	- -
Return on Assets (%)	- -	-666.52	-85.83	-82.48	-64.11	-46.55	-74.45	-128.1	-106.39	-167.91
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	94.67	8.7	5.43	74.45
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-42,484.8	-12,123.26	-2,846.2	-7,783.02
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-42,572	-12,146.3	-2,859.84	-7,829.75
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-44,201.87	-12,974.86	-2,630.14	-10,887.38
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-100.23	-70.35	-49.93	-111.08	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	1	2	1	94	101	103	110
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	25
LT Debt	- -	- -	- -	1	1	1	94	101	103	85
Total Debt/EBITDA	- -	-0.08	- -	-0.03	-0.02	-0.01	-0.59	-0.61	-1.6	-2.19
Net Debt/EBITDA	- -	0.11	2.13	0.97	2.6	2.18	0.63	-0.21	-1.13	-1.62
Total Debt/EBIT	- -	-0.08	- -	-0.03	-0.02	-0.01	-0.59	-0.6	-1.59	-2.18
Net Debt/EBIT	- -	0.11	2.13	0.97	2.59	2.18	0.63	-0.21	-1.12	-1.61
EBITDA to Interest Expense	- -	-2,268	- -	-1,672.25	-3,041.07	-2,665.98	-19.4	-12.57	-4.26	-2.94
EBITDA-CapEx/Interest Expense	- -	-2,268	- -	-1,715.75	-3,052.78	-2,677.1	-19.42	-12.57	-4.26	-2.94
EBIT to Interest Expense	- -	-2,268.5	- -	-1,680.05	-3,048.04	-2,673.4	-19.44	-12.59	-4.28	-2.96
Interest Expense	- -	- -	- -	- -	- -	- -	8	13	15	17
Common Equity/Total Assets	-4,628.57	-72.47	89.3	73.9	93.98	92.58	37.3	-76.67	-242.84	-212.54
Long-Term Debt/Equity (%)	- -	- -	- -	3.83	0.68	0.5	122.22	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	3.69	0.67	0.5	54.9	225.15	1,041.77	596.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.83	0.64	0.46	45.58	137.09	267.55	188.49
Total Debt/Equity (%)	- -	-37.78	- -	3.83	0.79	0.63	122.64	-179.42	-110.58	-114.87
Total Debt/Capital (%)	- -	-60.72	- -	3.69	0.78	0.63	55.08	225.92	1,045.57	772.46
Total Debt/Total Assets (%)	- -	27.38	- -	2.83	0.74	0.58	45.74	137.56	268.52	244.14
Net Debt to Equity	- -	52.55	-109.45	-120.57	-103.11	-105.1	-131.13	-62.61	-78.04	-85.04
Net Debt/Capital (%)	- -	34.45	1,157.92	720.26	4,451.11	2,352.5	441.67	-173.89	-363.12	-570.92
EBITDA	-2	-5	-20	-33	-82	-107	-159	-167	-64	-50
EBITDA-CapEx	-2	-5	-20	-34	-82	-107	-159	-167	-64	-50
Operating Income (Loss)	-2	-5	-20	-34	-82	-107	-160	-168	-65	-50

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.38	9.13	3.83	18	13.98	5.89	2.39	1.34	0.53
Current Ratio	0.01	0.38	9.26	4.03	18.33	14.21	6.17	2.65	1.68	0.83
Quick Ratio	- -	0.38	9.16	3.83	18	13.98	5.9	2.39	1.35	0.53
CFO/Avg Current Liab	- -	-1.65	-3.86	-4.13	-6.53	-5.76	-5.46	-5.15	-2.91	-1.51
Common Equity/Total Assets	-4,628.57	-72.47	89.3	73.9	93.98	92.58	37.3	-76.67	-242.84	-212.54
Long-Term Debt/Equity (%)	- -	- -	- -	3.83	0.68	0.5	122.22	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	3.69	0.67	0.5	54.9	225.15	1,041.77	596.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	2.83	0.64	0.46	45.58	137.09	267.55	188.49
Total Debt/Equity (%)	- -	-37.78	- -	3.83	0.79	0.63	122.64	-179.42	-110.58	-114.87
Total Debt/Capital (%)	- -	-60.72	- -	3.69	0.78	0.63	55.08	225.92	1,045.57	772.46
Total Debt/Total Assets (%)	- -	27.38	- -	2.83	0.74	0.58	45.74	137.56	268.52	244.14
CFO/Total Liabilities	-390.94	-93.97	-289.89	-285.36	-501.13	-462.26	-104.85	-119.04	-54.8	-41.04
CFO/CapEx	-323.5	- -	-39.73	-31.15	-209.97	-184.61	-973.68	-7,750.3	- -	- -
Altman's Z-Score	-1,055.83	-16.93	-1.21	-4.38	-1	-1.81	-4.37	-17.97	-28.79	-26.37

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	3.02	8.65	22.44	3.53
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	120.69	42.19	16.27	103.47
Inventory Turnover	- -	- -	- -	- -	- -	- -	0.02	0.63	1.61	0.23
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	18,113.12	575.89	227.38	1,559.04
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.27	0.11	0.06	0.01
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	1,356.78	3,442.71	6,510.26	27,058.49
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	16,877.04	-2,824.63	-6,266.62	-25,395.98
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-17,992.43	-533.7	-211.11	-1,455.57
Inventories	- -	- -	- -	- -	- -	- -	2	2	1	1
Raw Materials	- -	- -	- -	- -	- -	- -	1	1	1	- -
Work In Process	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	1	43	32	213	233	194	65	30	28
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	1	2	1	94	101	103	110
Enterprise Value	- -	-1	-43	-31	-211	-232	-100	36	73	81
Total Capital	- -	-1	39	28	208	223	171	45	10	14
Total Debt/Capital (%)	- -	-60.72	- -	3.69	0.78	0.63	55.08	225.92	1,045.57	772.46
Total Debt / EV	- -	-0.72	- -	-0.03	-0.01	-0.01	-0.95	2.8	1.41	1.35
EV/Sales	- -	- -	- -	- -	- -	- -	- -	26.21	32.26	126.55
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	-1	-43	-31	-211	-232	-100	36	73	81
EV per Share	- -	- -	- -	- -	- -	- -	- -	19.33	23.56	3.64
TTM Sales	- -	- -	- -	- -	- -	- -	- -	1	2	1
TTM EBITDA	-2	-5	-20	-33	-82	-107	-159	-167	-64	-50
TTM Operating Income	-2	-5	-20	-34	-82	-107	-160	-168	-65	-50
TTM Cash Flow to Firm	-1	-2	-14	-27	-66	-82	-127	-142	-57	-41
TTM Free Cash Flow to Firm	-1	-2	-13	-26	-66	-82	-127	-142	-57	-41

Multiples (USD)

Valuation Multiples API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-1	-43	-31	-211	-232	-100	36	73	81
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	26.21	32.26	126.55
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	26.21	32.26	126.55
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	26.21	32.26	126.55
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	26.21	32.26	126.55
EV/EBITDA Average	- -	0.11	2.13	0.94	2.58	2.17	0.62	-0.22	-1.13	-1.63
EV/EBITDA High	- -	0.11	2.13	0.94	2.58	2.17	0.62	-0.22	-1.13	-1.63
EV/EBITDA Low	- -	0.11	2.13	0.94	2.58	2.17	0.62	-0.22	-1.13	-1.63
EV/EBIT Average	- -	0.11	2.13	0.93	2.57	2.17	0.62	-0.22	-1.13	-1.62
EV/EBIT High	- -	0.11	2.13	0.93	2.57	2.17	0.62	-0.22	-1.13	-1.62
EV/EBIT Low	- -	0.11	2.13	0.93	2.57	2.17	0.62	-0.22	-1.13	-1.62
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Average	- -	-1	-43	-31	-211	-232	-100	36	73	81
Enterprise Value High	- -	-1	-43	-31	-211	-232	-100	36	73	81
Enterprise Value Low	- -	-1	-43	-31	-211	-232	-100	36	73	81

Shares Outstanding	1	1	1	1	2	2	2	2	3	22
Diluted Weighted Avg Shares	1	1	1	1	1	2	2	2	3	12
Basic Weighted Avg Shares	1	1	1	1	1	2	2	2	3	12
Revenue per Share	- -	- -	- -	- -	- -	- -	0.21	0.76	0.89	0.05
EBITDA per Share	-2.17	-4.78	-21.9	-32.85	-60.59	-64.7	-90.99	-91.9	-25.44	-4.09
Operating Income per Share	-2.17	-4.78	-21.92	-33	-60.73	-64.88	-91.18	-92.07	-25.56	-4.12
Basic EPS, GAAP	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Basic EPS from Cont Ops	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Diluted EPS, GAAP	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Diluted EPS from Cont Ops	-2.17	-4.78	-21.16	-32.38	-60.63	-64.87	-94.67	-98.35	-23.51	-5.73
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.32	-2.31	-14.83	-26.62	-48.96	-49.84	-77.3	-85.14	-28.41	-4.72
Free Cash Flow per Basic Share	-1.33	-2.31	-15.21	-27.47	-49.19	-50.11	-77.38	-85.15	-28.41	-4.72
Cash & Equivalents per Share	- -	0.93	43.48	28.68	139.65	133.22	110.12	34.87	9.62	1.27
Book Value per Share	-0.34	-1.03	39.73	23.79	135.44	126.76	43.64	-30.21	-30.01	-4.28
Tangible Book Value per Share	-0.34	-1.03	39.73	23.79	135.44	126.76	43.64	-30.21	-30.01	-4.28

BioXcel Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)